直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – December 2021

December 8, 2021

Authored and Edited by Y. Leon Lin; Gracie K. Mills; Elizabeth D. Ferrill

The following telephone arguments will be available to the public live. Access information will be available by 9 AM ET each day of argument at: https://cafc.uscourts.gov/home/oral-argument/listen-to-oral-arguments/.

Thursday, December 9, 2021

Polycom, Inc. v. directPacket Research, Inc., No. 21-1744

directPacket sued Polycom alleging infringement of U.S. Patent No. 7,710,978, and Polycom petitioned for IPR. The Board invalidated most claims as obvious, but a handful of dependent claims survived.

On appeal, Polycom argues these dependent claims are likewise obvious over the prior art and the Board’s decision must be reversed. According to Polycom, the Board applied an unduly narrow understanding of the law of obviousness, focusing inappropriately on minor differences between the prior art references to the exclusion of other motivations to combine them, including the nature of the problem to be solved. Polycom criticizes the Board for focusing on where a claimed limitation, “registering a network device,” occurs and finding a person of ordinary skill would not combine a prior art reference disclosing registration outside a firewall with a prior art reference disclosing registration inside a firewall. Polycom argues the Board framed the question too narrowly because there is no lexographic definition or disavowal of claim scope that would limit the claimed “registering” to being performed on either side of the firewall.

directPacket responds that the Board’s decision that there was no motivation to combine was firmly grounded in undisputed structural differences in the prior art references. According to directPacket, the Board’s decision did not rest on an “understanding of the law of obviousness” but on a question of fact, namely, how a person of ordinary skill would have understood the prior art references and whether that person would have been motivated to combine them. It argues that the substantial evidence standard of review applies, and such standard is easily met and shown in the Board’s decision.

Niazi Licensing Corporation v. St. Jude Medical S.C., Inc., No. 21-1864

Niazi Licensing Corporation (NLC) sued St. Jude for directly infringing Niazi’s U.S. Patent 6,638,268. During fact discovery, no witness testified to ever having used St. Jude’s accused products in an allegedly infringing manner. But following the close of fact discovery, NLC’s expert, Dr. Burke, included in his opening report a section titled “Evidence of Direct Infringement,” in which he alleged that he and others had in the past, at St. Jude’s direction, personally used St. Jude’s products in an allegedly infringing manner. St. Jude moved to strike Dr. Burke’s statements as untimely, which the district court granted. St. Jude moved for summary judgment of no direct infringement, which the district court also granted.

NLC appeals the district court’s grant of St. Jude’s motion to strike. NLC argues Dr. Burke’s statements were not only evidence of direct infringement, but also part of Dr. Burke’s credentials and a qualifying basis for his expert testimony. For this reason, NLC argues, the statements were not untimely, and the district court abused its discretion in excluding them. According to NLC, it was not aware of these facts until the expert discovery phase of the case, and there was no prejudice to St. Jude because no trial date had been set and St. Jude could have examined these statements during expert discovery.

St. Jude responds that NLC fails to demonstrate how the district court abused its discretion in excluding admittedly untimely and highly prejudicial factual disclosures. According to St. Jude, NLC does not dispute Dr. Burke’s statements were produced after the close of fact discovery. It notes NLC retained Dr. Burke before discovery closed and argues NLC thus could have obtained these statements sooner. It argues NLC’s failure to do so caused unfair surprise by converting Dr. Burke into a fact witness.

Tags

infringement, Spotlight on Upcoming Oral Arguments, United States Court of Appeals for the Federal Circuit (CAFC), Obviousness (35 USC § 103)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Related Industries

AI, Electronics, and Information Technology

Electronic Devices and Components

Communications

Life Sciences

Medical Device and Diagnostics

Related Offices

Washington, DC

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP